product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Caspase-9 (C9) Mouse mAb
catalog :
9508S
quantity :
100 ul
price :
235 USD
clonality :
monoclonal
host :
mouse
clone name :
C9
reactivity :
human, mouse, rat
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/DilutionReference
  • western blot (knockdown validation); human; 1:1000; fig 7A
Silva V, Plooster M, Leung J, Cassimeris L. A delay prior to mitotic entry triggers caspase 8-dependent cell death in p53-deficient Hela and HCT-116 cells. Cell Cycle. 2015;14:1070-81 pubmed publisher
  • western blot; human; 1:1000
Chou C, Huang N, Jhuang S, Pan H, Peng N, Cheng J, et al. Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions. PLoS ONE. 2014;9:e93934 pubmed publisher
  • western blot; human
Xu H, Shen Z, Xiao J, Yang Y, Huang W, Zhou Z, et al. Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect. BMC Cancer. 2014;14:668 pubmed publisher
product information
SKU :
9508S
Product-Name :
Caspase-9 (C9) Mouse mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Hm, Mk
Applications :
Western blot
Product-Category :
Apoptosis
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
47 /37/35 (H). 51 /39/37 (R,M).
Host :
Mouse
Target :
Casp9
Primary-Protein :
Casp9
Alt-Names :
APAF-3,APAF3,Apoptotic protease Mch-6,Apoptotic protease-activating factor 3,CASP-9,CASP9,CASPASE-9c,Caspase-9,Caspase-9 subunit p10,Caspase-9 subunit p35,ICE-LAP6,ICE-like apoptotic protease 6,MCH6,apoptotic protease activating factor 3,caspase 9, apoptosis-related cysteine peptidase,caspase 9, apoptosis-related cysteine protease
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.